Unknown OBSERVATIONAL NCT05667350

AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Biliary Tract Cancer (ASCEND-BTC)

Exploration and Validation of a Diagnosis Model for Biliary Tract Cancer Based on Combined Liquid Biopsy in Peripheral Blood: A Multi-center Prospective Study

Sponsor: Eastern Hepatobiliary Surgery Hospital

Conditions Biliary Tract Cancer

Interventions Blood drawing

Updated 5 times since 2023 Last updated: Dec 28, 2022 Started: Feb 28, 2022 Primary completion: Dec 31, 2023 Completion: Jun 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05667350, this observational or N/A phase trial focuses on Biliary Tract Cancer and remains ongoing. Sponsored by Eastern Hepatobiliary Surgery Hospital, it has been updated 5 times since 2022, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Jan 2025 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Jan 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Feb 2023 — Jul 2024 [monthly]

Recruiting
Jan 2023 — Feb 2023 [monthly]

Recruiting

First recorded

Feb 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eastern Hepatobiliary Surgery Hospital
Guangzhou Burning Rock Bioengineering Co., Ltd

Data source: Eastern Hepatobiliary Surgery Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China
• Shanghai, China